Elaine S. Ullian

Elaine S. Ullian, Director

Ms. Ullian has been a director of the Company since July 2001. Prior to her retirement in 2010, she served as President and Chief Executive Officer of Boston Medical Center. She previously served as President and Chief Executive Officer of Boston University Medical Center Hospital and Faulkner Hospital. She is currently also a director of Vertex Pharmaceuticals, Inc.

Thermo Fisher Scientific At a Glance

More than $24 billion in annual revenue and

70,000 Employees

Premier Brands

– Thermo Scientific

– Applied Biosystems

– Invitrogen

– Fisher Scientific

– Unity Lab Services

Read more

NYSE: TMO (Common Stock)Mar 25, 2019 12:07 PM

Exchange NYSE (US Dollar)NYSE

Price 268.03

Change +4.22  (+1.6%)

Volume 632,458

% Change

Intraday High 269.49

52 Week High 271.70

Intraday Low 264.01

52 Week Low 199.85

Today's Open 266.87

Previous Close 263.81

Minimum 20 minute delay

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit http://www.thermofisher.com.

The world leader in serving science